BridgeMD
New treatment option for Atrial Fibrillation
Official title Shock Energy for Electrical Cardioversion of Persistent Atrial Fibrillation
ClinicalTrials.gov ID: NCT05903170
What this study is testing
- What it's testing
- The goal of this clinical trial is to compare the efficacy of a maximum output shock for cardioverting atrial fibrillation between two commonly used defibrillators in New Zealand . These machines have different maximum energy outputs, and to date no head-to-head comparison cardioverting atrial fibrillation between the two has been undertaken.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Age \>18
- Patients undergoing either elective outpatient or non-emergent inpatient cardioversion for atrial fibrillation
- Eligible for anticoagulation
- Reliably anticoagulated for ≥three weeks prior to cardioversion, AF onset within 48hrs of cardioversion, or left atrial thrombus excluded on...
- Able to consent to cardioversion, and study participation
You likely can't join if
- Contraindication to anticoagulation
- Atrial flutter
- Emergent cardioversion
- Implantable cardiac device (PPM or ICD)
- Unable to consent to cardioversion and/or study participation
- Pregnancy
The study team makes the final eligibility decision.
Where it's taking place
- Wellington, Wellington Region, New Zealand
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Wellington, Wellington Region, New Zealand. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.